• 대한소아치과학회지
• /
• 제29권1호
• /
• pp.19-29
• /
• 2002

본 연구의 목적은 다양한 중합과정에 따른 복합레진과 컴포머의 수축 양상을 스트레인 게이지법(strain gauge method)을 이용하여 평가해보고자 하는 것이었다. 광중합기는 기존의 할로겐 시스템인 XL 3000(3M, USA)과 최근 소개된 plasma arc curing 시스템인 Flipo(LOKKI, France)를 사용하였고, 충전 재료는 복합레진인 Z-100(3M, USA)과 컴포머인 Dyract AP(Dentsply, Germany)를 사용하였다. 주형과 치아 와동 내에 충전된 실험재료의 중합수축을 각각 측정하였으며, 만능시험기를 이용하여 압축강도를 측정하였다. 중합수축 측정 결과 모두 중합초기에는 일시적인 재료의 팽창을 나타냈고, 그 후 약 1분간은 수축량이 급격히 증가하다가 증가의 폭이 점차 감소하는 양상을 보였다. 전반적으로 컴포머를 사용한 군에 비해 복합레진을 사용한 군에서 중합수축이 크게 나타났으며 plasma arc curing 시스템을 사용한 군에 비해 기존의 광조사 시스템 군에서 더 큰 중합수축을 보였다. 압축 강도의 측정결과는 컴포머 군에 비해 복합레진 군에서 크게 나타났다. 이상의 결과를 종합해 볼 때, plasma arc curing unit와 컴포머의 사용은 시술시간의 단축과 항우식 효과를 감안한다면 소아치과 영역에서의 사용이 긍정적으로 고려될 수 있다고 생각된다.

• Archives of Pharmacal Research
• /
• 제29권4호
• /
• pp.328-332
• /
• 2006

The bioequivalence and pharmacokinetics of alendronate sodium tablets were examined by determining the plasma concentration of alendronate. Two groups, consisting of 24 healthy volunteers, each received a 70 mg reference alendronate sodium tablet and a test tablet in a $2{\times}2$ crossover study. There was a 6-day washout period between doses. The plasma alendronate concentration was monitored for 7 h after the dose, using HPLC-Fluorescence Detector (FD). The area under the plasma concentration-time curve from time 0 to the last sampling time at 7 h $(AUC_{0-7h})$ was calculated using the linear-log trapezoidal rule. The maximum plasma drug concentration $(C_{max})$ and the time to reach $C_{max}(T_{max})$ were derived from the plasma concentration-time data. Analysis of variance was performed using logarithmically transformed $AUC_{0-7h}\;and\;C_{max}$, and untransformed $T_{max}$. For the test medication versus the reference medication, the $AUC_{0-7h}\;were\;87.63{\pm}29.27\;vs.\;102.44{\pm}69.96ng\;h\;mL^{-1}$ and the $C_{max}$ values were $34.29{\pm}13.77\;vs.\;38.47{\pm}24.39ng\;mL^{-1}$ respectively. The $90\%$ confidence intervals of the mean differences of the logarithmic transformed $AUC_{0-7h}$ and $C_{max}$ values were log 0.8234-log 1.1597 and log 0.8222-log 1.1409, respectively, satisfying the bioequivalence criteria guidelines of both the US Food and Drug Administration and the Korea Food and Drug Administration. The other pharmacokinetic parameters for the test drug versus reference drug, respectively, were: $t_{1/2},\;1.87{\pm}0.62\;vs.\;1.77{\pm}0.54\;h;\;V/F,\;2061.30{\pm}986.49\;vs.\;2576.45{\pm}1826.05\;L;\;CL/F,\;835.32{\pm}357.35\;vs.\;889.48{\pm}485.87\;L\;h^{-1}; K_{el},\;0.42{\pm}0.14\;vs.\;0.40{\pm}0.18\;h^{-1};\;Ka,\;4.46{\pm}3.63\;vs.\;3.80{\pm}3.64\;h^{-1};\;and\;T_{lag},\;0.19{\pm}0.09\;vs.\;0.18{\pm}0.06\;h$. These results indicated that two alendronate formulations(70-mg alendronate sodium) were biologically equivalent and can be prescribed interchangeably.

• 한국재료학회지
• /
• 제9권9호
• /
• pp.878-882
• /
• 1999

분자선증착법으로 (0001) 사파이어 기판 위에 $Al_xGa_1-_xN$ 에피층을 AlN 몰비를 변화시키면서 성장시켰다. AlN 몰비는 0.16에서 0.76까지 변화시켰으며 X선의 회절 실험과 Rutherford backscattering spectroscopy 방법을 이용하여 AlN 몰비를 결정하였다. $Al_xGa_1-_xN$ 에피층의 깊이 방향의 조성 변화를 관찰하였으며 스퍼터 시간에 대해 각 원소가 일정한 원자 농도를 가짐을 알 수 있었다. AlN 몰비의 증가에 따른 표면 특성의 변화를 관찰하기 위하여 atomic force microscopy 측정을 수행하였다. 표면에서의 입자 모양이 AlN 몰비가 변화함에 따라 원형에서 침상형태로 변화함을 알 수 있었다. 표면 입자에 대한 root mean square 값과 average roughness 값을 구하였으며 AlN 몰비를 바꿈에 따라 나타나는 변화를 관찰하였다.

• 분석과학
• /
• 제12권5호
• /
• pp.408-414
• /
• 1999

기체 크로마토그래피-전자포획검출기 (gas chromatograph-electron capture detector : GC-ECD)를 이용하여 사람의 혈액 내에 존재하는 homocysteine (Hcy), 관련 화합물인 cysteine (Cys)과 methionine (Met)에 대해 선택적이고 감도 좋은 분석방법에 대하여 연구하였다. 시료는 혈장 내에서 환원과정을 거친 후 ethyl chloroformate (ECF)와 pentafluoropropyl alcohol (PEP-OH) 유도체화 시약을 사용하여 N(O,S)-ethylearhonyl pentafluoropropyl (PEP) ester 유도체를 만들어 추출의 효율을 높이면서 동시에 GC-ECD에 대한 크로마토그래피 성질을 향상시켰다. 생성된 유도체들은 chloroform으로 추출한 후 잔류물을 완전히 건조시키고 hexane으로 추출하여 GC-ECD로 분석하였다. Hcy와 Met는 $5-50{\mu}mol/L$, Cys는 $40-400{\mu}mol/L$ 범위에서 $R^2=0.990$ 이상의 직선상의 상관관계를 나타내었다. 이 작성한 질량곡선을 통해서 5명의 자원자들의 혈액 중에 존재하는 Hcy, Cys, met의 함량을 분석하였다.

• 분석과학
• /
• 제26권4호
• /
• pp.221-227
• /
• 2013

LC-MS/MS를 이용하여 인체 혈장 중 ginsenoside Rg1의 신속하고 정확한 분석법을 개발하고 이 분석법에 대한 검증을 수행하였다. 혈장 분석을 위하여 internal standard인 digoxin을 첨가한 후 acetone과 methanol용액 (80:20)으로 전처리하고, 그 상층액을 진공농축 한 후, LC-MS/MS로 분석하였다. 최적 크로마토그래피 분석은 0.1% formic acid 첨가된 water와 methanol을 이동상으로 하여 Agilent Eclipse XDB-C18 column ($4.6{\times}150mm$, $5{\mu}m$)을 이용하여 0.9 mL/min의 유속으로 gradient mode로 수행하였다. 혈장 중 ginsenoside Rg1의 표준 검량선은 1~500 ng/mL의 농도 범위에서 우수한 직선성($r^2=0.9995$)을 보였으며, 일내, 일간 정밀성은 변동계수 7.53% 이하, 정확성은 98.28% 이상이었다. 결과적으로 본 분석법은 ginsenoside Rg1의 약동학 연구에 적용되기에 충분한 감도와 특이성, 직선성, 정밀성 및 정확성을 가지고 있음을 확인하였다.

• 대한지역사회영양학회지
• /
• 제3권5호
• /
• pp.695-706
• /
• 1998

This study was designed to investigate the associations of the percent body fat dietary intake, plasma lipoprotein profile, lipoprotein(a), and plasminogen activator inhibitor-1(PAI-1) concentrations of 1982 Korean subjects(men : 1000 and women : 982) between the ages of 40 and 59 years. The dietary assessment consisted of twenty-four hour dietary records and food frequency questionnaires. The subjects were identified into one of the five rating groups of % body fat : lean, underweight, normal, overweight and obese groups. The biochemical assessment included measurements of plasma total cholesterol(TC), HDL-cholesterol(HDL-C), LDL-cholesterol(LDL-C), triglyceride(TG), lipoprotein(a)(Lp(a)), and PAI-1. With respect to the ratio of percent energy intake of carbohydrate : protein : fat of the normal group of the women was 62% : 17% : 20%, respectively. Women apparently had a higher intake of carbohydrates than men(52% : 17 : 20%) did. There was a linear relationship between energy intake and % body fat in both mean and women(with the exception of the underweight group of women). The relationship of % body fat of men to the protein and fat intake was higher than that of the carbohydrate intake. Of the men in the study, intakes of energy, protein and alcohol were positively correlated to % body fat. In women, energy, carbohydrate and protein intake were positively correlated to % body fat, however, the fat, cholesterol and alcohol intake did not show any correlation to the % body fat in women. This study showed that % body fat was positively correlated with plasma TC, LDL-C, PAI-1 levels, and TG, but the % body fat was negatively correlated with plasma HDL-C level in both men and women. These results indicated that the high energy intake of obese or overweight subjects might contribute to several of the biochemical indices fo coronary heart disease(CHD) risk. In conclusion, increased energy intake is associated with overweight or obesity in middle aged Korean people. There was no relationship between % energy intake of fat and % body fat in the study, in middle-aged Korean men and women. The plasma lipid profile and PAI-1 level thought to be the risk factors of CHD were positively associated with percent body fat in middle aged Korean people.

• Journal of Pharmaceutical Investigation
• /
• 제36권5호
• /
• pp.343-348
• /
• 2006

The purpose of the present study was to evaluate the bioequivalence of two zolpidem tartrate tablets, Stilnox tablet(Sanofi-aventis Korea, reference product) and Zanilo tablet(ChoDang Pharm Co., Ltd., Korea, test product), according to the guidelines of Korea Food and Drug Administration(KFDA). After adding an internal standard(cimetropium), 250 ${\mu}L$ plasma samples were extracted using 1.3 mL of ethyl acetate. Extracted compounds were analyzed by HPLC with triple-quadrupole mass spectrometry. This method for determination of zolpidem is proved accurate and reproducible with the limit of quantitation of 1 ng/mL in human plasma. Twenty-four healthy male Korean volunteers received each medicine at the zolpidem tartrate dose of 10 mg in a $2{\times}2$ crossover study. There was one-week washout period between the doses. Plasma concentrations of zolpidem were monitored for over a period of 8 hr after the administration. $AUC_{0-t}$(the area under the plasma concentration-time curve) was calculated by the linear trapezoidal rule. $C_{max}$(maximum plasma drug concentration) and $T_{max}$(time to reach $C_{max}$) were compiled from the plasma concentration-time data. Analysis of variance was carried out using logarithmically transformed $AUC_{0-t}$ and $C_{max}$. No significant sequence effect was found for all of the bio-availability parameters indicating that the crossover design was properly performed. The 90% confidence intervals for the log transformed data were acceptable range of log 0.8 to log 1.25(e.g., log 0.92-log 1.06 for $AUC_{0-t}$, log 0.96-log 1.13 for $C_{max}$). The major parameters, $AUC_{0-t}$ and $C_{max}$ met the criteria of KFDA for bioequivalence indicating that Zanilo tablet is bioequivalent to Stilnox tablet.

• 분석과학
• /
• 제21권1호
• /
• pp.34-40
• /
• 2008

LC-MS/MS를 이용하여 신속하고 정확한 혈장 중 레르카니디핀의 분석법을 개발하고 이 분석법에 대한 검증을 수행하였다. 혈장에 내부표준물질로 사용한 암로디핀을 첨가한 후 아세토니트릴로 단백질을 침전시키고, 그 상층액을 취하여 건조시킨 후 50 % 아세토니트릴로 재용해하여 LC-MS/MS로 분석하였다. MS/MS의 MRM (multiple reaction monitoring) 방법을 이용하여 혈장 중 레르카니디핀을 어떠한 분석의 방해물 없이 선택적으로 검출할 수 있었다. 레르카니디핀의 표준 검량선은 0.05-20 ng/mL의 농도 범위에서 우수한 직선성(r = 0.9994)을 보였으며, 일내, 일간 재현성은 변동계수 11.7% 이하, 정확성은 94.4-114.8%로 레르카니디핀의 약물동력학적 연구에 적용되기에 충분한 감도와 특이성, 직선성, 정밀성 및 정확성을 가지고 있음을 확인하였다.

• 대한유전성대사질환학회지
• /
• 제17권2호
• /
• pp.39-47
• /
• 2017

Purpose: A sensitive gas chromatography mass spectrometry (GC-MS) method was developed for screening of fatty acid oxidation disorders. Methods: The assay utilized a simple protein precipitation with sulfosalicylic acid followed by tert-butyl dimethylsilyl (TBDMS) derivatization of hydroxyl functional group by N-tert-butyldimethylsilyl-N-methyltrifluoroacetamide (MTBSTFA). Results: Calibration curves of spiked pooled plasma showed a linear relationship in the range of 0.01 ng -2 mg with correlation coefficient value greater than 0.98. Limits of detection (LOD) and limits of quantification (LOQ) were found in the range of 0.9-8.8 ng and 9-88 ng, respectively. Conclusion: The new developed method might be useful for a rapid, sensitive screening of inherited fatty acid oxidation disorders. In addition, the method expected to be one of the alternative method for screening newborns of metabolic disorders in the laboratories where expensive MS/MS is unavailable.

• Archives of Pharmacal Research
• /
• 제28권9호
• /
• pp.1092-1096
• /
• 2005

Huperzine A-loaded microspheres composed of poly(D,L-lactide-co-glycolide) were prepared by an O/w emulsion solvent evaporation method. The characterization of the microspheres such as drug loading, size, shape and release profile was described. The in vitro release in the initial 7 days was nearly linear with $10\%$ released per day. Thereafter drug release rate became slow gradually and about $90\%$ drug released at day 21. The in vitro release rate determined by dialysis bag method had a good correlation with the in vivo release rate. Huperzine A aqueous solution was intramuscularly injected (i.m.) at 0.4mg/kg and microspheres were intra­muscularly injected at 8.4 mg eq huperzine A/kg in rats. The maxium plasma concentration $(C_{max})$ after i.m. microspheres was only $32\%$ of that after i.m. solution. Drug in plasma could be detectd until day 14 and about $5\%$ of administered dose was residued at the injection site at day 14. The relative bioavailability of huperzine A microspheres over a period of 14 days was $94.7\%$. Inhibition of acyecholinesterase activity (AchE) in rat's cortex, hippocampus and striatum could sustain for about 14 days. In conclusion, huperzine A-loaded microspheres possessed a prolonged and complete drug release with significant inhibition of AchE for 2 weeks in rats.